Nineteen eighty-four was a particular moment in American transplant medicine. Cyclosporine, introduced in 1983, had dramatically improved organ rejection rates and made transplantation viable for a much wider patient population. The number of transplant centers was growing. The number of patients who could benefit from transplant was growing faster. The ad hoc regional coordination systems that had developed — including the Southeast Organ Procurement Foundation and the North American Transplant Coordinators Organization — were insufficient for national scale. Congress acted.
The National Organ Transplant Act made two structural choices that would shape the system for the next four decades. First, it created the Organ Procurement and Transplantation Network as a private nonprofit contractor rather than a new government agency. Second, it prohibited compensation for organ donation, establishing the altruistic framework that continues to govern American organ procurement. Both choices were defensible responses to the conditions of 1984. Neither choice was made with full anticipation of its long-term consequences.
Private nonprofit OPTN contractor
Avoid creating a new government bureaucracy. Leverage the clinical expertise and existing relationships of the transplant professional community. Enable flexible, expert-driven governance of a technically complex medical system.
Created conditions for a single incumbent organization to accumulate decades of institutional knowledge, proprietary data infrastructure, and political position — making meaningful competition at each renewal cycle practically impossible without disrupting patient care.
Prohibition on organ sales (§301)
Prevent commodification of organ donation. Preserve the altruistic basis of the gift relationship. Align with WHO and international ethical norms favoring voluntary unpaid donation.
Maintained the ethical framework for donation that has broad public support. Also created structural scarcity — with no price signal to increase supply, allocation rather than market mechanisms must govern distribution. The quality of allocation architecture becomes the critical variable.
HHS oversight of OPTN contract
Federal accountability for the national system. HRSA to award and oversee the contract; CMS to certify and reimburse OPOs. Distributed oversight across the existing agency structure.
Distributed oversight with no unified accountability mandate. HRSA oversaw the contractor; CMS oversaw the OPOs; neither was clearly responsible for the system's aggregate performance. The gap between agencies became the gap in accountability that this series has documented.
OPTN membership mandatory for transplant centers
Ensure all centers participate in the national system, enabling consistent data collection, allocation policy application, and quality standards across all transplant programs.
Mandatory membership created the revenue architecture examined in Post V: every transplant center must pay fees to the organization governing them. The regulator's financial dependence on the regulated was structurally embedded from the beginning.
HRSA had the authority to competitively rebid the OPTN contract at each renewal cycle. The law did not prohibit competition — it specified a private nonprofit contractor, not UNOS specifically. In principle, any qualified nonprofit organization could have submitted a competing proposal at any renewal. In practice, no competitor ever successfully challenged UNOS's hold on the contract across 37 years and multiple renewal cycles.
Understanding why requires understanding what the OPTN contract actually entailed at each renewal. By the time of the first renewal, UNOS had built the UNet matching system — proprietary software that managed the national waitlist and ran the allocation algorithm. It had established working relationships with all 57 OPOs and hundreds of transplant centers. It had accumulated years of historical data on donor and recipient outcomes. It employed the staff with institutional knowledge of the system's operations. A competitor proposing to take over the OPTN contract would have been proposing to rebuild all of this from scratch — while patients remained on the waitlist and organs continued to require matching in real time.
HRSA did not protect UNOS's monopoly. It failed to challenge it. The difference matters. Active protection implies conspiracy. Passive failure implies something more common and more durable: the risk calculus of disruption outweighing the cost of incumbency, every renewal cycle, for 37 years.
National Organ Transplant Act
Congress creates OPTN as private nonprofit contractor model. Prohibits organ sales. Mandates HHS oversight via HRSA. Does not name UNOS — creates the position, not the occupant.
UNOS awarded first OPTN contract
HRSA awards to UNOS, evolving from SEOPF regional network. UNOS has existing infrastructure, relationships, and technical capability. Reasonable first award. The 37-year clock starts.
Contract renewed · No competitive challenge
UNOS builds UNet system. Accumulates proprietary data. Establishes relationships with all OPOs and transplant centers. Each renewal increases switching cost. No credible competitor emerges. HRSA accepts — switching risks real, performance concerns not yet critical.
GAO reports document performance gaps · Contract continues
Multiple GAO and OIG reports identify oversight weaknesses, data transparency issues, and governance concerns. HRSA responds with process requirements. UNOS agrees with recommendations. Contract renewed. Performance improvement within existing structure is the default response — not structural change.
Media exposés, whistleblowers, reform advocacy · Contract continues
LA Times, NYT, and investigative outlets document operational failures. Whistleblowers raise safety concerns. Patient advocacy organizations push for reform. HRSA conducts reviews. UNOS implements improvements. Contract renewed. The disruption argument holds: changing the system mid-operation risks patient harm.
Senate Finance Committee investigation · Documented failures
Wyden/Grassley investigation documents complaint handling failures, IT security gaps, governance conflicts, executive compensation, and operational safety incidents. The congressional record now contains specific, documented failures with named consequences. The disruption argument becomes harder to sustain than the accountability argument.
The durability of UNOS's contract position is explained by four interlocking mechanisms that accumulated over time, each reinforcing the others. None was designed to prevent competition. All had that effect.
Data Lock-In
Proprietary Historical Record
UNOS held decades of waitlist data, outcome records, and allocation history — all in proprietary UNet infrastructure with limited government access. A competitor would begin without this data. Outcomes research, algorithm refinement, and policy analysis all depend on historical data the incumbent controlled. HRSA did not have full access to the system it was funding.
Relationship Lock-In
Institutional Network Dependency
UNOS had operating relationships with all 57 OPOs, hundreds of transplant centers, and thousands of transplant professionals over decades. These relationships governed the daily coordination of organ procurement and allocation. A new contractor would inherit the formal mandate but not the institutional trust and working relationships built over 37 years.
Technical Lock-In
UNet System Complexity
The UNet matching system — proprietary code running the national organ allocation algorithm — represented enormous accumulated technical investment. Replicating it would require years and significant resources. During any transition, organ allocation would continue to operate. The risk of transition errors in a life-critical system was a genuine argument against changing contractors, used effectively against competition.
Political Lock-In
Disruption Risk Argument
Any proposal to change the OPTN contractor could be opposed on patient safety grounds — disrupting a life-critical system risks patient harm. UNOS and its allies in the transplant professional community deployed this argument at each reform moment. It was not dishonest. Transition does carry risk. But it was also structurally convenient for the incumbent, and it was used to resist accountability as effectively as it was used to protect patients.
The formal mechanism for maintaining competition in government contracting is the competitive rebid — requiring the incumbent to compete against other qualified bidders at each renewal. For most federal contracts, this works reasonably well. For the OPTN contract, it faced a specific problem: the switching costs were genuine, and they were denominated in patient lives.
Data migration
Moving decades of waitlist records, outcome data, and allocation history from proprietary UNOS infrastructure to a new contractor's systems. Risk of data loss, integrity failures, and gaps in the allocation record.
High
Algorithm continuity
A new contractor would need to replicate or replace the UNet matching algorithm. Any changes to allocation logic affect which patients receive organs. Algorithm transition during active waitlist operation risks systematic misallocation.
Critical
OPO relationship disruption
57 OPOs have established protocols, communication channels, and working relationships with UNOS staff. A new contractor would need to rebuild these operational relationships while organs were being recovered and allocated in real time.
High
Institutional knowledge loss
UNOS staff held decades of institutional knowledge about edge cases, policy interpretations, and operational practices not fully documented in any contract or manual. This knowledge cannot be transferred — it must be rebuilt.
High
Transition window risk
The period between contract handoff and full operational capability of a new contractor is a period of elevated error risk in a system where errors can be fatal. No equivalent federal contract manages a similarly life-critical real-time operational system.
Critical
Political opposition
Any rebid proposal would trigger organized opposition from UNOS, the transplant professional community, and patient advocacy groups aligned with system continuity. The incumbent could always argue that competition risked patient harm. This argument is not false — but it also protects the incumbent from accountability.
Structural
The Securing the US OPTN Act of 2023 solved the switching cost problem by not trying to switch the whole system at once. Instead of a single competitive rebid — which would face all of the transition risks described above simultaneously — the legislation broke the OPTN contract into functional components: IT and matching systems, operations, safety oversight, governance support, and research. Each component could be competitively awarded separately. A new IT contractor could take over the UNet system over time while UNOS continued operating the matching algorithm. A new safety organization could provide oversight without disrupting procurement logistics.
This was the right structural solution. It addressed the lock-in mechanisms directly — the data lock-in through IT separation, the algorithm continuity risk through staged transition, the relationship disruption risk through operational continuity provisions. Whether it produces better outcomes depends on implementation. The first multi-vendor cycle is underway as of 2025–2026, and its results are the subject of Post VIII.
37
Years · No Challenge
Duration between NOTA's passage and the first legislation requiring competitive multi-vendor contracting for OPTN operations
5
Contract Components
Number of functional categories the 2023 act broke the single OPTN contract into — enabling competition without single-system transition risk
1984
The Origin
The year two reasonable legislative decisions created the structural conditions for a 37-year monopoly that 40 years of subsequent policy failed to challenge
FSA Note · Contract Architecture
The OPTN contract is a study in how incumbency accumulates into monopoly through the ordinary operation of switching costs, not through conspiracy or explicit protection. The decisions that created the conditions for UNOS's hold on the contract were made in 1984 for defensible reasons. The failure to challenge that hold across 37 renewal cycles was driven by genuine risk calculations at each cycle — disrupting a life-critical system is a real cost, not a pretext. But the aggregate outcome of individually rational decisions was a system that could not be held accountable for its performance, because the cost of replacing it was always calculated as higher than the cost of tolerating it. That calculation is the lock-in mechanism at its most complete. It does not require bad faith. It only requires that the disruption risk be real enough, and the incumbency protection be durable enough, that the status quo survives every reform moment until a legislative mechanism is finally applied that the administrative mechanism never produced.
Next · Post VII · The Spain Divergence — 52+ donors per million population. The Spanish Model as structural contrast. What the architecture looks like when the incentives are aligned differently.
Posts
No comments:
Post a Comment